The resources below are available to download for your information and record keeping.

Guidance for how a HealthCare Professional can prescribe iAluRil® for you and how you can have it dispensed to your home. View the Guidance Document

Patient Diary – Use this to keep a record of your instillations while not attending your usual clinic. the information you record will be of use to your clinician once the Urology service can resume in hospitals. View the Patient Diary

Patient information leaflet – this leaflet will provide you with all the information you need to understand what iAluRil is, how it is administered, how long treatment would typically last and what to expect in terms of potential side effects. View the Patient Information

iAluAdapter tip sheet – a step by step guide to using the iAluadapter to self-administer your iAluRil without the need to perform self-catheterisation View the iAluAdapter tip sheet

ISC instructions for Women – A handy step – by – step guide to administering your iAluRil via a catheter. View the ISC instructions for Women

ISC instructions for Men – A handy step – by – step guide to administering your iAluRil via a catheter. View the ISC instructions for Men

Common challenges with ISC – a tip sheet for common issues experienced by those performing intermittent self-catheterisation (ISC) View the Common challenges with ISC

What is IC / PBS? – a leaflet explaining the condition and how you, as a patient, can manage your symptoms and take control. What is IC / PBS?

What is rUTI? – a leaflet explaining the causes and symptoms of recurrent Urinary Tract Infections, and some simple easy steps you can take to help prevent it from recurring. View What is rUTI?

Disposing of iAluRil waste
Any waste after iAluRil administration can be disposed of with normal household waste.

Essential Information
iAluRil Prefill for intravesical instillation Indication: To re-establish the glycosaminoglycan layers (GAGs) of the urothelial vesical tissue in cases in which their loss can cause frequent and recurring problems (such as, cystitis of varying etiology). Active Ingredients: Sodium hyaluronate (1.6%), Sodium chondroitin sulphate (2%) and Calcium chloride (0.87%). Please read the full patient information leaflet for further information and before administration. iAluRil should only be used after careful consultation with a trained healthcare professional.
Reporting of Side Effects
If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in the product’s package leaflet. You can also report side effects directly via the Yellow Card Scheme at www.mhra.gov.uk/yellowcard. By reporting side effects you can help provide more information on the safety of this medical device.
Revision reference – iAluRil_10 28/05/2020